MedBlog

Digestive; Nutrition; Prevention

A breakthrough in Type 1 diabetes: What it might mean for children

Teplizumab, a Type 1 diabetes immunotherapy drug, has been proven to slow onset of the disease by 2 years. This landmark discovery could lead to potential reduction in long-term health risks related to diabetes. Find out how the drug works and who might benefit in this week’s MedBlog. Learn more.

Sasan Mirfakhraee, M.D.

November 6, 2019